VerbaFlo.AI | $7,000,000 | (Mar 18, 2026)
Surf AI(1) | $57,000,000 | (Mar 18, 2026)
R1 Therapeutics | $77,500,000 | (Mar 18, 2026)
Lumafield
United States
- Cambridge, Massachusetts
- 13/09/2022
- Series B
- $35,000,000
Lumafield is here to make it possible for humanity to solve our hardest problems as quickly as possible.
Lumafield has developed the world's first accessible X-Ray CT scanner for engineers. Lumafield’s easy-to-use scanner and cloud-based software give engineers the ability to see their work clearly, inside and out, at an extremely affordable price.
Engineers make million-dollar decisions every day, and they need tools that give them the greatest possible insight into their products. By offering unprecedented visibility into products, as well as AI-driven tools that highlight problems and generate quantitative data, Lumafield promises to revolutionize the way complex products are created, manufactured, and used across industries.
Founded in 2019, our team includes world-class researchers and industrial designers, PhDs, founders of successful startups, and zero egos.
The company is headquartered in Boston, MA and has an office in San Francisco, CA.
- Industry Computer Hardware Manufacturing
- Website https://www.lumafield.com/
- LinkedIn https://www.linkedin.com/company/lumafield/about/
Quorus | $5,000,000 | (Mar 18, 2026)
BambooBox | $6,600,000 | (Mar 18, 2026)
iDEL Therapeutics GmbH | $10,381,635 | (Mar 18, 2026)
Conduit Health | $17,000,000 | (Mar 18, 2026)
SEQUENTIAL | $3,500,000 | (Mar 18, 2026)
Standard Template Labs | $49,000,000 | (Mar 18, 2026)
Tenkara | $7,000,000 | (Mar 18, 2026)
Turquoise(US) | $40,000,000 | (Mar 18, 2026)
AgZen | $10,000,000 | (Mar 17, 2026)